Mar. 30, 2019 |
|
Jan. 26, 2024 |
|
jRCTs051180229 |
ALS biomarker research using patient clinical samples |
|
ALS biomarker research |
Inoue Haruhisa |
||
Kyoto University |
||
53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan |
||
+81-75-366-7360 |
||
prj-als_bosutinib@cira.kyoto-u.ac.jp |
||
Inoue Haruhisa |
||
Kyoto University |
||
53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan |
||
+81-75-366-7360 |
||
prj-als_bosutinib@cira.kyoto-u.ac.jp |
Recruiting |
Mar. 31, 2019 |
||
April. 19, 2019 | ||
49 | ||
Interventional |
||
non-randomized controlled trial |
||
open(masking not used) |
||
historical control |
||
parallel assignment |
||
basic science |
||
Those who agree to attend the current clinical study among ALS patients joining an accompanying clinical trial "Phase 1/2 Dose Escalation Study of Bostinib in Patients with Amyotrophic Lateral Sclerosis (ALS)" |
||
N/A |
||
20age old over | ||
75age old under | ||
Both |
||
amyotrophic lateral sclerosis (ALS) |
||
collection of cerebrospinal fluid |
||
ALS |
||
Alteration of blood biomerkers including SOD1, TDP-43, Src, c-Abl, etc. |
||
N/A |
Japan Agency for Medical Research and Development | |
Not applicable |
Kyoto University Certified Review Board | |
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN, Kyoto | |
+81-75-753-4680 |
|
ethcom@kuhp.kyoto-u.ac.jp | |
Approval | |
Mar. 04, 2019 |
No |
|
none |